About Alpha Clinics
The CIRM-funded Alpha Stem Cell Clinics are a network of top California medical centers. The Network specializes in delivering stem cell clinical trials to patients. The key to the Network’s success is the ability to accelerate the delivery treatments to patients through partnerships with patients, medical providers and clinical trial sponsors. These partnerships enable:
- Patient-centered clinical trials with the highest standards of care and research
- Strategic collaboration with academic and industry teams developing innovative stem cell therapies
- Leveraging of resources to promote efficiency, acceleration and increased chances of success
The Network supports both CIRM-funded and non CIRM-funded clinical trials by academic and industry sponsors. The Network partners include the Stem Cell Center – a Contract Research Organization (CRO) providing end-to-end solutions for clinical trial sponsors.
If you are a patient or a trial sponsor interested in learning more about the services offered through our Alpha Clinics Network, download the following flyers by clicking on the icons below, or contact us at firstname.lastname@example.org.
Our Alpha Clinics
The CIRM Alpha Stem Cell Clinic Network consists of five leading medical centers throughout California. In 2015, the Network was launched in southern California at the City of Hope, UC Irvine, UC Los Angeles, and UC San Diego. In September 2017, CIRM awarded funding to UC Davis and UC San Francisco to enable the Network to better serve patients throughout the state.
To learn more about participating Alpha Clinics—including information on enrolling in current and future clinical trials—please visit each clinic's dedicated webpage*.
CIRM Alpha Clinic Videos
The 2nd Annual CIRM Alpha Stem Cell Clinic Symposium was held in March, 2017 at the City of Hope. You can watch videos of all the speakers on the City of Hope YouTube channel.
A clinical trial at the City of Hope Alpha Stem Cell Clinic brings hope for patients with glioblastoma, an aggressive form of brain cancer. A patient with late stage glioblastoma was treated with a cell-based immunotherapy called CAR T-cells. After ten treatments, the patient's tumors disappeared and didn't return for seven months.
In May 2015, the three Network programs from UCSD, City of Hope, and the UCLA/UCI consortium joined CIRM at the City of Hope campus for a kickoff workshop to mark the beginning of the endeavor. This short video is based on that workshop and features interviews with each trial center’s program director.